Medtronic To Pay $55M In HeartWare Investor Suit
Executive Summary
Device-giant Medtronic has agreed to pay $54.5m to settle a class-action suit filed by investors in HeartWare, which Medtronic bought in 2016. The plaintiffs say HeartWare misled investors about the safety of a miniaturized heart pump under development.
You may also be interested in...
Medtronic Ups Its Heart-Failure Competitive Strength With HeartWare Buy
The deal gives Medtronic its first ventricular-assist devices and gives struggling HeartWare a needed boost.
HeartWare Updates Status Of Battles On Several Fronts
HeartWare is counting on its established HVAD technology to carry it through a difficult period as it struggles to relaunch the clinical trial of the MVAD miniaturized ventricular assist device.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.